• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号
首页- Products - Others - Other Targets - 2,2-Dimethyl-5-(2,5-xylyloxy)valeramide

2,2-Dimethyl-5-(2,5-xylyloxy)valeramide

CAS No. 114413-97-7

2,2-Dimethyl-5-(2,5-xylyloxy)valeramide ( 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanamide )

产品货号. M28379 CAS No. 114413-97-7

2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥405 有现货
10MG ¥608 有现货
25MG ¥1037 有现货
50MG ¥1555 有现货
100MG ¥2325 有现货
200MG ¥3491 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    2,2-Dimethyl-5-(2,5-xylyloxy)valeramide
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.
  • 产品描述
    2,2-Dimethyl-5-(2,5-xylyloxy)valeramide is a chemical compound.
  • 同义词
    5-(2,5-dimethylphenoxy)-2,2-dimethylpentanamide
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Na+/H+-exchanger (NHE)
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    114413-97-7
  • 分子量
    249.4
  • 分子式
    C15H23NO2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    Cc1ccc(C)c(OCCCC(C)(C)C(N)=O)c1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Timothy A. Ayers, et al. Process for preparing 2-chloro-3n-(2-benzimidazolyl)-4-methyl-3-thienylamine useful as a sodium/proton exchanger type 3 inhibitor. WO2011019784A1
产品手册
关联产品
  • IGF-I (24-41) TFA (1...

    IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth Factor I (IGF-I).

  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • Helenine

    Alantolactone(Alant camphor), a sesquiterpene lactone, has potential activity against triple-negative breast Y MDA-MB-231 cells by suppressing the signal transducer and activator of transcription 3 (STAT3) signaling pathway.